The global forskolin market was valued at USD 586.92 Million in 2024, driven by increasing health consciousness, the rising demand for natural supplements, and growing awareness of forskolin's potential benefits for weight management and metabolic health across the globe. The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2025-2034 to achieve a value of USD 1101.73 Million by 2034.
Base Year
Historical Period
Forecast Period
The rise in chronic diseases like obesity and cardiovascular issues is also contributing to the demand for forskolin, as it is perceived to be effective in managing these conditions.
Forskolin's high medicinal value has led to its increased use in the pharmaceutical industry, thereby, contributing to market growth.
One of the major market trends include forskolin gaining popularity as a weight loss aid due to its potential benefits in reducing body fat and enhancing muscle mass.
Compound Annual Growth Rate
6.5%
Value in USD Million
2025-2034
Forskolin Market Outlook
*this image is indicative*
Forskolin, derived from the Indian medicinal plant Coleus forskohlii, has potential medicinal properties. It's been traditionally used in Ayurvedic medicine and is being investigated for its effects on conditions like glaucoma, heart failure, asthma, and obesity. While some studies suggest positive effects, more clinical research is needed to confirm its efficacy and understand its mechanisms. Forskolin can lower intraocular pressure by increasing cyclic AMP (cAMP) levels, which reduces the production of aqueous humor in the eye. It may have inotropic effects, potentially improving heart muscle contraction.
Rising Global Obesity Epidemic
The global obesity crisis is a primary driver of the forskolin market, with the World Health Organization (WHO) reporting that obesity rates have tripled since 1975 affecting over 650 million adults worldwide. By 2035, projections indicate 1.53 billion individuals will be obese, with 79% in low- and middle-income countries (LMICs). This surge has intensified demand for natural weight management solutions, positioning forskolin, a plant-derived metabolism booster, as a sought-after supplement. Government is also prioritizing obesity interventions. For instance, the U.S FDA recently approved the first GLP-1 drug, liraglutide for Type 2 diabetes, a sign of burgeoning focus on metabolic health. Forskolin’s commercial growth is based upon its response to this public health challenge.
Expansion into Cosmetic and Anti-Aging Applications
Forskolin is increasingly utilized in premium skincare fueled by its anti-inflammatory and antioxidant properties. The aging global population, projected to reach 1.6 billion people aged 65 and above by 2050 driving this trend. In Europe, a sizable proportion of this market is concentrated and forskolin-infused products target cellulite reduction and skin elasticity. The Asia-Pacific region, notably India, leverages traditional Ayurvedic knowledge to develop forskolin-based cosmetics with the sector growing significantly every year. This diversification beyond supplementation into cosmetics capitalizes on the USD 430 billion beauty industry in agreement with clean-label preferences.
Pharmaceutical Integration for Metabolic and Respiratory Conditions to Boost Forskolin Market Demand
Forskolin is gaining significant traction in pharmaceutical application, the fastest among all applications. This trend is fueled by clinical research, validating its efficacy in managing respiratory disorders like asthma, affecting 25 million American and metabolic conditions such as obesity, which impacts 41.9% of the US adults. Pharmaceutical companies are increasing incorporating standardized forskolin extracts into therapeutic formulation, particularly following recent advancement in drug delivery systems. For instance, the introduction of Sanofi’s Eurekaflox, a forskolin derived asthma treatment in 2023, highlights its expanding clinical utility.
High Concentration (>95%) to Lead the Segmentation by Concentration
The high concentration (>95%) of forskolin dominates the global market because of its enhanced potency and effectiveness in different applications, pharmaceuticals, dietary supplements, and cosmetics. This high purity extract delivers desired results with smaller doses, making them a popular choice for manufacturers and consumers alike. High concentration forskolin is preferred in formulations targeting weight management, cardiovascular health, and skincare as it works better than other concentrations.
North America sees an immense and rising chronic disease burden with obesity and cardiovascular being core public health challenges. This drives the demand for forskolin-based supplements. A growing number of consumers in North America are moving towards natural and plant-based products, like forskolin, for weight management and general wellness. The region boasts a well-established and robust health supplement industry, facilitating the availability and promotion of forskolin-based products.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Sabinsa Corporation
Sabinsa Corporation is a key player in the forskolin market, particularly known for their branded ForsLean® product, which is a standardized extract of Coleus forskohlii, a plant in the mint family. They have been involved in extensive research and development related to forskolin, including its use in supporting lean body mass and weight management. Sabinsa has also secured patents for various forskolin applications, including its use in glaucoma treatment and for promoting lean body mass.
Nutra Green Biotechnology
Nutra Green Biotechnology is a company specializing in the research, development, and supply of natural and herbal raw materials, particularly for the health, wellness, and nutraceutical industries. They focus on plant-based extracts and compounds, including forskolin, and are known for their commitment to quality and sustainability.
Varion Lifesciences Pvt. Ltd.
Varion Lifesciences Pvt. Ltd. is a pharmaceutical and nutraceutical company based in Mumbai, India. They specialize in the manufacture of specialty ingredients, including novel plant extracts like Forskolin, as well as Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations. The company operates with two state-of-the-art facilities that meet GMP requirements and has a strong domestic and global presence in its operating product categories.
Alchem International Pvt Ltd.
Alchem International Pvt Ltd is a global leader in the production of plant-derived active ingredients for the pharmaceutical, cosmetic, and nutraceutical industries. Founded in 1935, the company has over 75 years of experience and operates three manufacturing sites in India, with four international divisions across India, Europe, Hong Kong, and the United States. Alchem is known for its expertise in phytochemicals and its commitment to quality and compliance, with regulatory dossiers filed in over 20 countries.
Other key players include Cymbio Pharma Pvt Ltd., Glentham Life Sciences, Flavour Trove, and Alpspure Lifesciences Pvt. Ltd.
“Forskolin Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Breakup by Concentration
Breakup by Application
Breakup by End Use
Breakup by Region
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is assessed to grow at a CAGR of 6.50% between 2025 and 2034.
The major drivers of the industry, such as rising disposable incomes, increasing population, enhancing standards of living, rising demand for herbal supplements, increasing inclination towards natural and plant-based products, and rising health consciousness, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising demand for organic products and growing technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading concentrations of forskolin in the industry are low concentration (10%), medium concentration (20%-40%), and high concentration (95%).
The major application segments in the market are allergy treatment, weight management, respiratory problems, cardiovascular disorders, glaucoma, hypothyroidism, and psoriasis, among others.
The significant end-use sectors in the industry are nutraceuticals, pharmaceuticals, and dietary supplements, among others.
The major players in the market are Sabinsa Corporation, Nutra Green Biotechnology Co., Ltd., Varion Lifesciences Pvt. Ltd., Alchem International Pvt Ltd, and Cymbio Pharma Pvt Ltd, among others.
In 2024, the market attained a value of nearly USD 586.92 Million.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach about USD 1101.73 Million by 2034.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Concentration |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
